Taiwan sets up fund for international biotech expertise
This article was originally published in Clinica
Taiwan is to establish a biotechnology fund to invest in the latest technologies from the US, Canada and Europe. Some NT$1.1 billion ($34.3 million) will be raised by various government agencies and private companies and at least 10 new key technologies are expected to be transferred to Taiwan in the next five years, the China Economic News Service reports.
You may also be interested in...
After urging the US Congress to act on updating Medicare Part D, the Association for Accessible Medicines has welcomed the decision to update Part D by the Centers for Medicare & Medicaid Services of the US Department of Health and Human Services.
Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and an “India-first” approach for specialty products. Uptick in the China business and the potential launch of a Russia-partnered COVID-19 vaccine were other aspects of the business discussed at JPM.
“You can’t just live off the brand equity anymore,” warned J&J's Consumer Health's Minoj Raghunandanan during the ‘Advancing Trust in the Self-Care Industry’ webinar co-hosted by the Global Self-Care Federation and HBW Insight. “You’ve got to continue to build that trust between consumers and products day-in day-out.”